Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea

International Journal of Obesity

Volumn 39, Issue 3, 2015, Pages 418-423

  Carreras, A ^a   Zhang, S X ^a   Peris, E ^a   Qiao, Z ^a   Wang, Y ^a   Almendros, I ^a   Gozal, D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; PROTEIN KINASE B; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; ANTIOBESITY AGENT; STILBENE DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERLEPTINEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SLEEP DISORDERED BREATHING; SLEEP FRAGMENTATION; SLEEP PARAMETERS; VISCERAL WHITE ADIPOSE TISSUE; WEIGHT GAIN; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; EATING; LIPID DIET; METABOLISM; OBESITY; PATHOLOGY;

MUS;

ANIMALS; ANTI-OBESITY AGENTS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EATING; INFLAMMATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MICE; MICE, INBRED C57BL; OBESITY; SLEEP APNEA SYNDROMES; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 84924668090     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2014.181     Document Type: Article

References (40)

1. Wang Y, Carreras A, Lee SH, Hakim F, Zhang SXL, Nair D, et al. Chronic fragmented sleep promotes obesity in mice. Obesity 2014; 22: 758-762
2. Khalyfa A, Wang Y, Zhang SX, Qiao Z, Abdelkarim A, Gozal D. Sleep fragmentation in mice induces nicotinamide adenine dinucleotide phosphate oxidase 2-dependent mobilization, proliferation, and differentiation of adipocyte progenitors in visceral white adipose tissue. Sleep 2014; 37: 999-1009
3. Zhang SX, Khalyfa A, Wang Y, Carreras A, Hakim F, Neel BA, et al. Sleep fragmentation promotes NADPH oxidase 2-mediated adipose tissue inflammation leading to insulin resistance in mice. Int J Obes 2014; 38: 619-624
4. Nair D, Zhang SX, Ramesh V, Hakim F, Kaushal N, Wang Y, et al. Sleep fragmentation induces cognitive deficits via nicotinamide adenine dinucleotide phosphate oxidase-dependent pathways in mouse. Am J Resp Critic Care Med 2011; 184: 1305-1312
5. Ramesh V, Nair D, Zhang SX, Hakim F, Kaushal N, Kayali F, et al. Disrupted sleep without sleep curtailment induces sleepiness and cognitive dysfunction via the tumor necrosis factor-Alpha pathway. J Neuroinflammation 2012; 9: 91
6. Kaushal N, Ramesh V, Gozal D. TNF-α and temporal changes in sleep architecture in mice exposed to sleep fragmentation. PLoS One 2012; 7: e45610
7. Möller-Levet CS, Archer SN, Bucca G, Laing EE, Slak A, Kabiljo R, et al. Effects of insufficient sleep on circadian rhythmicity and expression amplitude of the human blood transcriptome. Proc Natl Acad Sci USA 2013; 110 : E1132-E1141
8. Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 2010; 137: 95-101
9. van den Berg SW, Jansen EH, Kruijshoop M, Beekhof PK, Blaak E, van der Kallen CJ, et al. Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study). Diabet Med 2008; 25: 186-193
10. van den Berg SW, Dollé ME, Imholz S, van der A DL, van "t Slot R, Wijmenga C, et al. Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: a population-based cohort study. Int J Obes (Lond) 2009; 33: 1143-1152
11. Hubbard BP, Sinclair DA. Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol Sci. 2014; 35: 146-154
12. Hausenblas HA, Schoulda JA, Smoliga JM. Resveratrol treatment as an adjunct to pharmacological management in Type 2 diabetes mellitus-systematic review and meta-Analysis. Mol Nutr Food Res 2014
13. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008; 8: 157-168
14. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444: 337-342
15. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127: 1109-1122
16. Ramesh V, Kaushal N, Gozal D. Sleep fragmentation differentially modifies EEG delta power during slow wave sleep in socially isolated and paired mice. Sleep Sci 2009; 2: 64-75
17. Sargis RM, Neel BA, Brock CO, Lin Y, Hickey AT, Carlton DA, et al. The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1levels. Biochim Biophys Acta 2012; 1822: 952-960
18. Hakim F, Wang Y, Carreras A, Hirotsu C, Zhang J, Peris E, et al. Chronic sleep disruption during the sleep period induces hypothalamic endoplasmic reticulum stress and PTP1b-mediated leptin resistance in mice. Sleep 2014 (in press
19. Zhu J, Yong W, Wu X, Yu Y, Lv J, Liu C, et al. Anti-inflammatory effect of resveratrol on TNF-Alpha-induced MCP-1 expression in adipocytes. Biochem Biophys Res Commun. 2008; 369: 471-477
20. Gonzales AM, Orlando RA. Curcumin and resveratrol inhibit nuclear factor-kappaBmediated cytokine expression in adipocytes. Nutr Metab (Lond) 2008; 5: 17
21. Olholm J, Paulsen SK, Cullberg KB, Richelsen B, Pedersen SB. Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int J Obes (Lond) 2010; 34: 1546-1553
22. Jimenez-Gomez Y, Mattison JA, Pearson KJ, Martin-Montalvo A, Palacios HH, Sossong AM, et al. Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell Metab 2013; 18: 533-545
23. Wright DC. Exercise-And resveratrol-mediated alterations in adipose tissue metabolism. Appl Physiol Nutr Metab 2014; 39: 109-116
24. Schneider Y, Duranton B, Gossé F, Schleiffer R, Seiler N, Raul F. Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 2001; 39: 102-107
25. Norata GD, Marchesi P, Passamonti S, Pirillo A, Violi F, Catapano AL. Anti-inflammatory and anti-Atherogenic effects of cathechin, caffeic acid and transresveratrol in apolipoprotein E deficient mice. Atherosclerosis 2007; 191: 265-271
26. Qureshi AA, Guan XQ, Reis JC, Papasian CJ, Jabre S, Morrison DC, et al. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor. Lipids Health Dis 2012; 11: 76
27. Cho SJ, Jung UJ, Choi MS. Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice. Br J Nutr 2012; 108: 2166-2175
28. Bakker GC, van Erk MJ, Pellis L, Wopereis S, Rubingh CM, Cnubben NH, et al. An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am J Clin Nutr 2010; 91: 1044-1059
29. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808
30. Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM, et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005; 54: 2305-2313
31. Hernandez ED, Lee SJ, Kim JY, Duran A, Linares JF, Yajima T, et al. A Macrophage NBR1-MEKK3 Complex Triggers JNK-Mediated Adipose Tissue Inflammation in Obesity. Cell Metab 2014; 20: 499-511
32. Cipolletta D. Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential. Immunology 2014; 142: 517-525
33. Garg SK, Delaney C, Shi H, Yung R. Changes in adipose tissue macrophages and T cells during aging. Crit Rev Immunol 2014; 34: 1-14
34. Lee BC, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta. 2014; 1842: 446-462
35. Lal G, Bromberg JS. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 2009; 114: 3727-3735
36. Akasheh RT, Pang J, York JM, Fantuzzi G. New pathways to control inflammatory responses in adipose tissue. Curr Opin Pharmacol 2013; 13: 613-617
37. Farghali H, Kutinová Canová N, Lekić N. Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets. Physiol Res 2013; 62: 1-13
38. Qin W, Zhang K, Clarke K, Weiland T, Sauter ER. Methylation and miRNA effects of resveratrol on mammary tumors vs normal tissue. Nutr Cancer 2014; 66: 270-277
39. Kim J, Bhattacharjee R, Khalyfa A, Kheirandish-Gozal L, Capdevila OS, Wang Y, et al. DNA methylation in inflammatory genes among children with obstructive sleep apnea. Am J Respir Crit Care Med 2012; 185: 330-338
40. Tan HL, Gozal D, Wang Y, Bandla HP, Bhattacharjee R, Kulkarni R, et al. Alterations in circulating T-cell lymphocyte populations in children with obstructive sleep apnea. Sleep 2013; 36: 913-922.